Valuation: Baxter International Inc.

Capitalization 9.79B 8.42B 7.64B 7.33B 13.38B 903B 13.86B 89.75B 35.94B 430B 36.75B 35.96B 1,537B P/E ratio 2026 *
31.5x
P/E ratio 2027 * 21.4x
Enterprise value 16.28B 14B 12.7B 12.18B 22.25B 1,501B 23.05B 149B 59.74B 716B 61.1B 59.79B 2,556B EV / Sales 2026 *
1.43x
EV / Sales 2027 * 1.34x
Free-Float
74.36%
Yield 2026 *
0.21%
Yield 2027 * 0.22%
1 week-8.20%
Current month-6.58%
1 month-9.51%
3 months+2.98%
6 months-19.30%
Current year-0.42%
1 week 18.46
Extreme 18.465
20.48
1 month 18.46
Extreme 18.465
22.41
Current year 18.46
Extreme 18.465
22.41
1 year 17.4
Extreme 17.4
37.74
3 years 17.4
Extreme 17.4
50.21
5 years 17.4
Extreme 17.4
89.7
10 years 17.4
Extreme 17.4
95.19
Manager TitleAgeSince
Chief Executive Officer 49 31/07/2025
Director of Finance/CFO 56 17/10/2023
Chief Tech/Sci/R&D Officer - 31/12/2020
Director TitleAgeSince
Director/Board Member 75 05/02/2017
Director/Board Member 66 17/02/2019
Director/Board Member 65 31/12/2018
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-8.20%-45.30%-52.35% 9.79B
-0.45%-1.45%-17.79%+8.28% 197B
-1.15%-1.09%+2.76%+14.61% 123B
-0.87%+1.42%+45.37%+135.79% 71.62B
+2.64%-3.65%+58.40%+99.57% 58.8B
-1.56%-5.23%-23.53%-27.71% 48.83B
-3.40%-11.00% - - 34.8B
-0.25%-0.36%-11.55%-40.69% 28.06B
-0.12%-3.40%+7.64%+27.97% 23.84B
-2.27%-4.11%-7.92%-24.14% 18.73B
Average -0.49%-3.67%+0.90%+15.70% 61.38B
Weighted average by Cap. -0.12%-2.39%+2.84%+28.00%

Financials

2026 *2027 *
Net sales 11.35B 9.76B 8.86B 8.5B 15.52B 1,047B 16.07B 104B 41.67B 499B 42.62B 41.7B 1,783B 11.6B 9.97B 9.05B 8.68B 15.85B 1,069B 16.42B 106B 42.57B 510B 43.54B 42.6B 1,821B
Net income 360M 310M 281M 269M 492M 33.19B 510M 3.3B 1.32B 15.83B 1.35B 1.32B 56.53B 483M 415M 377M 361M 660M 44.49B 683M 4.42B 1.77B 21.22B 1.81B 1.77B 75.78B
Net Debt 6.49B 5.58B 5.06B 4.85B 8.86B 598B 9.18B 59.46B 23.81B 285B 24.35B 23.82B 1,018B 5.81B 4.99B 4.53B 4.35B 7.94B 535B 8.22B 53.25B 21.32B 255B 21.8B 21.33B 912B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
04/03/26 19.03 $ 0.00% 8,653,038
03/03/26 19.03 $ -3.35% 9,039,603
02/03/26 19.69 $ -3.34% 7,287,906
27/02/26 20.37 $ +0.05% 36,636,902
26/02/26 20.36 $ -1.78% 7,145,554
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
19.03USD
Average target price
21.63USD
Spread / Average Target
+13.68%

Quarterly revenue - Rate of surprise